China approves second Coronavirus vaccine CoronaVac

▴ China approves second Coronavirus vaccine CoronaVac
Sinovac's Coronavac jab is the second vaccine to be approved by Chinese authorities

China's drug authorities have given "conditional" approval for a second Covid-19 vaccine, Sinovac's CoronaVac jab, the pharmaceutical company said Saturday.

The vaccine has already been rolled out to key groups at higher risk of exposure to coronavirus but Saturday's approval allows for its use on the general public.

A conditional approval helps hustle emergency drugs to market in cases when clinical trials are yet to meet normal standards but indicate therapies will work.

The approval comes after multiple domestic and overseas trials of the vaccine in countries including Brazil and Turkey, although "efficacy and safety results need to be further confirmed", Sinovac said in a statement.

Fellow Chinese pharmaceutical company Sinopharm received a similar conditional green light in December to put its vaccine on the market.

Sinovac said trials in Brazil had shown around 50 per cent efficacy in preventing infection and 80 percent efficacy in preventing cases requiring medical intervention.

"The results show that the vaccine has good safety and immunogenic effect on people of all age groups," Sinovac said Saturday.

Meanwhile, Sinopharm said in December that its vaccine had a 79.34 per cent efficacy rate, lower than rival jabs developed in the West by Pfizer-BioNTech and Moderna -- with 95 and 94 per cent rates respectively.

China has been racing to develop homegrown jabs and aims to vaccinate 50 million people before the start of the Lunar New Year in mid-February.

The holiday normally spurs a travel rush with hundreds of millions traversing the country -- though authorities are encouraging people to stay home this year through a mixture of restrictions and incentives.

As China ramps up its vaccine campaign, authorities have repeatedly assured the public of the jab's safety and efficacy, despite not releasing any detailed clinical trial data.

At the same time, Beijing has been promoting its vaccines abroad in what analysts have called "vaccine diplomacy" to earn goodwill after facing criticism for its early handling of the outbreak.

China's foreign ministry on Wednesday said it planned to provide 10 million vaccine doses to the WHO-backed international vaccine distribution programme Covax.

Beijing has also pledged to share the vaccine at a fair cost -- a potential boost for poorer Asian countries who are otherwise reliant on limited distribution offered by the Covax scheme.

Countries including Senegal, Indonesia, and Hungary have procured millions of vaccine doses from Chinese pharmaceutical firms.

But take-up has been slower abroad for Chinese vaccines compared to jabs from Pfizer-BioNTech and Moderna, as little information has been published about the safety or efficacy of Chinese vaccines.

Chinese vaccine makers also have chequered reputations, after major scandals at home involving expired or poor quality products.

Story Courtesy

www.indiatoday.com 

AFP

Tags : #Coronavac #Sinovac #CoronavacJab #ChineseVaccines #ChinaVaccineNews #Beijing #Covaxin #Covax #VaccineDiplomacy #WHO

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Dish TV Revolutionizes Entertainment with ‘Dish TV Smart+’ Services, Offering TV and OTT on Any Screen, AnywhereApril 26, 2024
Arohan Financial Services Recognized Among India's Best Workplaces in BFSI 2024April 26, 2024
Why Podcasts Are the Next Big Thing in Healthcare Advertising in IndiaApril 26, 2024
Challenges of Child Growth at High Altitudes: New Study Reveals ImpactApril 26, 2024
Staying Cool in India's Scorching Heat: Heatwave Safety TipsApril 26, 2024
The Dark Side of Neotame (Artificial Sweetener): New Research Raises Concerns about Gut HealthApril 26, 2024
Sightsavers India Fellowship Program Invites Applications for Promising OphthalmologistsApril 25, 2024
Transforming Brain Healthcare: India's Visionary Task Force for Neurological DisordersApril 25, 2024
The Battle Against Malaria: Rising Trends and Vaccine InnovationsApril 25, 2024
Talc and Asbestos Controversy: Inside Johnson & Johnson's Courtroom StruggleApril 25, 2024
The Hidden Struggles of Parenthood: Addressing Isolation, Loneliness, and BurnoutApril 25, 2024
FDA Confirms Bird Flu Virus Remnants in Pasteurized Milk: Safety and Regulatory InsightsApril 24, 2024
Sarvodaya Hospital Redefines Total Knee Replacement Surgery with Augmented Reality April 23, 2024
Fateh Education announces partnership to expand educational opportunities for Indian studentsApril 23, 2024
10 Strategies to counter disinformation for the healthcare digital ecosystemApril 23, 2024
Is Selling Over-the-Counter (OTC) Drugs in General Stores A Step Towards Affordable Healthcare in IndiaApril 23, 2024
Student Health Crisis: Food Poisoning Incident Strikes Pune Coaching CentreApril 23, 2024
The Impact of Diabetes on Kidney Health: Diabetic Nephropathy ExplainedApril 23, 2024
Toddler Hospitalized After Consuming Expired Chocolates: Health Concerns RaisedApril 23, 2024
After months of diagnostic delay, a migrant worker could access TB services only when a community health worker met himApril 22, 2024